Shandong Sito Bio-technology Management

Management Kriterienprüfungen 0/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Lianbiao Jin

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	no data
Eigentum des Geschäftsführers	n/a
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	keine Daten

Jüngste Management Updates

Recent updates

Why We're Not Concerned Yet About Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 26% Share Price Plunge

Jun 06

There May Be Reason For Hope In Shandong Sito Bio-technology's (SZSE:300583) Disappointing Earnings

May 05

Risks Still Elevated At These Prices As Shandong Sito Bio-technology Co., Ltd. (SZSE:300583) Shares Dive 30%

Apr 16

Geschäftsführer

Lianbiao Jin (59 yo)

no data

Amtszeit

Mr. Lianbiao Jin is General Manager of Shandong Sito Bio-technology Co., Ltd.

Shandong Sito Bio-technology Management

Management Kriterienprüfungen 0/4

Wichtige Informationen

Jüngste Management Updates

Shandong Sito Bio-technology Co., Ltd., Annual General Meeting, Jun 21, 2024

Less than half of directors are independent

Recent updates

Shandong Sito Bio-technology Co., Ltd. to Report First Half, 2024 Results on Aug 27, 2024

Why We're Not Concerned Yet About Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 26% Share Price Plunge

There May Be Reason For Hope In Shandong Sito Bio-technology's (SZSE:300583) Disappointing Earnings

Shandong Sito Bio-technology Co., Ltd., Annual General Meeting, Jun 21, 2024

First quarter 2024 earnings released: EPS: CN¥0.02 (vs CN¥0.088 in 1Q 2023)

Risks Still Elevated At These Prices As Shandong Sito Bio-technology Co., Ltd. (SZSE:300583) Shares Dive 30%

Investor sentiment deteriorates as stock falls 20%

Shandong Sito Bio-technology Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024

Investor sentiment deteriorates as stock falls 16%

Shandong Sito Bio-technology Co., Ltd. to Report Fiscal Year 2023 Results on Mar 30, 2024

Investor sentiment improves as stock rises 21%

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.066 (vs CN¥0.053 in 3Q 2022)

Investor sentiment deteriorates as stock falls 19%

New major risk - Share price stability

New major risk - Shareholder dilution

Investor sentiment deteriorates as stock falls 44%

Investor sentiment improves as stock rises 16%

New minor risk - Share price stability

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: CN¥0.41 (vs CN¥0.18 in 2Q 2022)

Shandong Sito Bio-technology Co., Ltd. to Report First Half, 2023 Results on Aug 15, 2023

Shandong Sito Bio-Technology Co., Ltd. Approves Cash Dividend/10 Shares for 2022

First quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.12 in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.084 (vs CN¥0.12 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.23 in 2Q 2021)

Investor sentiment improved over the past week

Shandong Sito Bio-Technology Co., Ltd. Announces Cash Dividend for A Shares for the Year 2021, Payable on 05 July 2022

Shandong Sito Bio-technology Co., Ltd. announced that it expects to receive CNY 298.0822 million in funding

Shandong Sito Bio-technology Co., Ltd. Approves Cash Dividend for the Year 2021

Shandong Sito Bio-Technology Co., Ltd. Proposes Final Dividend for 2021

First quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.05 loss in 1Q 2021)

Second quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.12 loss in 2Q 2020)

Shandong Sito Bio-Technology Co., Ltd. Omits to Pay Dividend for the Year 2020

First quarter 2021 earnings released: CN¥0.05 loss per share (vs CN¥0.23 loss in 1Q 2020)

Shandong Sito Bio-technology Co., Ltd. to Report Fiscal Year 2020 Results on Apr 20, 2021

New 90-day low: CN¥19.49

New 90-day low: CN¥23.14

New 90-day low: CN¥26.06

New 90-day low: CN¥28.21

Third quarter earnings released

New 90-day high: CN¥31.63

First half earnings released

Shandong Sito Bio-technology Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

Geschäftsführer

Amtszeit